Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1993-6-4
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0305-7453
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
31
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
443-5
|
| pubmed:dateRevised |
2001-11-26
|
| pubmed:meshHeading |
pubmed-meshheading:8486581-Amoxicillin,
pubmed-meshheading:8486581-Amoxicillin-Potassium Clavulanate Combination,
pubmed-meshheading:8486581-Clavulanic Acids,
pubmed-meshheading:8486581-Drug Combinations,
pubmed-meshheading:8486581-Gram-Negative Bacteria,
pubmed-meshheading:8486581-Microbial Sensitivity Tests
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Problems associated with susceptibility testing of co-amoxiclav.
|
| pubmed:publicationType |
Letter
|